Great Valley Advisor Group, Inc.
- SEC CIK
- 0001769897
- Latest filing
- Aug 10, 2026
BCRX holding history
Biocryst Pharmaceuticals Inc in every 13F filed by Great Valley Advisor Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −16,400−100.0% | Sold out | Holders |
| Q3 2024 | 16,400 | $124.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 16,400 | $101.4K | <0.1% | −1,000−5.7% | Reduced | Holders |
| Q1 2024 | 17,400 | $88.3K | <0.1% | +1,100+6.7% | Added | Holders |
| Q4 2023 | 16,300 | $97.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 16,300 | $115.4K | <0.1% | +4,200+34.7% | Added | Holders |
| Q2 2023 | 12,100 | $85.2K | <0.1% | +1,800+17.5% | Added | Holders |
| Q1 2023 | 10,300 | $85.9K | <0.1% | +10,300 | New | Holders |